NCT01768455View on ClinicalTrials.gov

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

April 30, 2013

Conditions
Healthy
Interventions
DRUG

Gemigliptin and Glimepiride

Gemigliptin 50mg (qd) on Day1\~Day6 and Gemigliptin 50mg (qd) and Glimepiride 4mg (qd) on Day7

DRUG

Glimepiride

Glimepiride 4mg (qd) on Day1

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
lead

LG Life Sciences

INDUSTRY